Wound healing process and mediators: Implications for modulations for hernia repair and mesh integration
Emmanuel E. Sadava
Case Comprehensive Hernia Center, Department of Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047
Search for more papers by this authorDavid M. Krpata
Case Comprehensive Hernia Center, Department of Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047
Search for more papers by this authorYue Gao
Case Comprehensive Hernia Center, Department of Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047
Search for more papers by this authorMichael J. Rosen
Case Comprehensive Hernia Center, Department of Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047
Search for more papers by this authorCorresponding Author
Yuri W. Novitsky
Case Comprehensive Hernia Center, Department of Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047
Correspondence to: Y. W. Novitsky; e-mail: [email protected]Search for more papers by this authorEmmanuel E. Sadava
Case Comprehensive Hernia Center, Department of Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047
Search for more papers by this authorDavid M. Krpata
Case Comprehensive Hernia Center, Department of Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047
Search for more papers by this authorYue Gao
Case Comprehensive Hernia Center, Department of Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047
Search for more papers by this authorMichael J. Rosen
Case Comprehensive Hernia Center, Department of Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047
Search for more papers by this authorCorresponding Author
Yuri W. Novitsky
Case Comprehensive Hernia Center, Department of Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047
Correspondence to: Y. W. Novitsky; e-mail: [email protected]Search for more papers by this authorAbstract
In recent years, major advances have been accomplished in abdominal wall reconstruction. Introduction of newer prostheses have improved outcomes, but elimination of mesh-related morbidity is still an elusive issue. It is believed that host foreign body reaction to prosthesis plays an important role in the biology of these complications, so understanding of the molecular mechanisms behind mesh–tissue interactions may be a key for upcoming therapies. It appears that increasing biocompatibility of both synthetic prosthesis and biologic scaffolds might be the main avenues to achieve better outcomes. This manuscript provides an overview of major effectors of wound healing with particular emphasis on how their modulation might improve outcomes in tissue remodeling and mesh integration. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 295–302, 2014.
REFERENCES
- 1Leber GE, Garb JL, Alexander AI, Reed WP.Long-term complications associated with prosthetic repair of incisional hernias.Arch Surg1998; 133: 378–382.
- 2Voyles CR, Richardson JD, Bland KI, Tobin GR, Flint LM, Polk HC Jr.Emergency abdominal wall reconstruction with polypropylene mesh: Short-term benefits versus long-term complications.Ann Surg1981; 194: 219–223.
- 3Kumar S, Wilson RG, Nixon SJ, Macintyre IM.Chronic pain after laparoscopic and open mesh repair of groin hernia.Br J Surg2002; 89: 1476–1479.
- 4White TJ, Santos MC, Thompson JS.Factors affecting wound complications in repair of ventral hernias.Am Surg1998; 64: 276–280.
- 5Weyhe D, Hoffmann P, Belyaev O, Mros K, Muller C, Ulh W, Schmitz F.The role of TGF-β1 as a determinant of foreign body reaction to alloplastic materials in rat fibroblast cultures: Comparison of different commercially available polypropylene meshes for hernia repair.Regul Pept2007; 138: 10–14.
- 6Singer AJ, Clark RAF.Cutaneous wound healing.N Engl J Med1999; 341: 738–746.
- 7Gosain A, DiPietro LA.Aging and wound healing.World J Surg2004; 28: 321–326.
- 8Witte M, Abarbul A.General principles of wound healing.Surg Clin North Am1997; 3: 509–528.
- 9Luger TA, Stadler BM, Luger BM, Mathieson BJ, Mage M, Schmidt JA, Oppenheim JJ.Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin-1.J Immunol1982; 128: 2147–2152.
- 10Alheim K, Bartfai T.The interleukin-1 system: Receptors, ligands, and ICE in the brain and their involvement in the fever response.Ann NY Acad Sci1998; 840: 51–58.
- 11Graves DT, Nooh N, Gillen T, Davey M, Patel S, Cottrel D, Amar S.IL-1 plays a critical role in oral, but not dermal, wound healing.J Immun2001; 167: 5316–5320.
- 12Raja, Sivamani K, Garcia MS, Isseroff RR.Wound reepithelialization: Modulating keratinocyte migration in wound healing.Front Biosci2007; 12: 2849–2868.
- 13Tang A, Gilchrest BA.Regulation of keratinocyte growth factor gene expression in human skin fibroblasts.J Dermatol Sci1996; 11: 41–50.
- 14Labow M, Shuster D, Zetterstrom M, Nunes P, Terry R, Cullinan EB, Bartfai T, Solorzano C, Moldawer LL, Chizzonite R, Mclntyre KW.Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice.J Immunol1997; 5: 2452–2461.
- 15Yamada H, Mizumo S, Horai R, Iwakura Y, Sugawara I.Protective role of interleukin-1 in mycobacterial infection in IL-1 −/− double-knockout mice.Lab Invest2000; 5: 759–767.
10.1038/labinvest.3780079 Google Scholar
- 16Hart J.Inflammation. 1: Its role in the healing of acute wounds.J Wound Care2002; 11: 205–209.
- 17Jung JC, Huh MI, Fini ME.Contitutive collagenase-1 synthesis through MAPK pathways madiated, in part, by endogenous IL-1alpha during fibrotic repair in corneal stroma.J Cell Biochem2007; 102: 453–462.
- 18Chen C-P, Hertzberg M, Jiang Y, Graves DT.Interleukin-1 and tumor necrosis factor receptor signaling is not required for bacteria-induced osteoclastogesis and bone loss but is issencial for potecting the host from mixed anaerobic infection.Am J Pathol1999; 155: 2145–2152.
- 19Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F.Principles of interleukin (IL)-6-type cytokine signalling and its regulation.Biochem J2003; 374: 1–20.
- 20Orenstein S, Qiao Y, Kaur M, Klueh U, Kreutzer DL, Novitsky YW.Human monocyte activation by biologic and biodegradable meshes in vitro.Surg Endosc2010; 24: 805–811.
- 21Hurst SM, Vilkison TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N, Rose-John S, Fuller GM, Topley N, Jones SA.IL-6 and it solute receptor orchestrate a temporal switch in the patter of leukocyte recruitment seen during acute inflammation.Immunity2001; 14: 705–714.
- 22Jones SA.Directing transition from innate to acquired immunity: Definig a role for IL-6.J Immunol2005; 175: 3463–3468.
- 23Barton BE.IL-6: Insights into novel biological activities.Clin Immunol Immunopathol1997; 85: 16–20.
- 24Park JY, Pillinger MH.Interleukin-6 in the pathogenesis of rheumatoid arthritis.Bull NYU Hosp Jt Dis2007; 65: S4–S10.
- 25Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Köhler G.Impaired immune and acute-phase responses in interleukin-6–deficient mice.Nature1994; 368: 339–342.
- 26Lin Z-Q, Kondo T, Ishida Y, Takayasu T, Mukaida N.Essential involvement of IL-6 en the skin wound-healing process as evidenced by delayed wound-healing in IL-6-deficietn mice.J Leukoc Biol2003; 73: 713–721.
- 27Gallucci RM, Simeonova PP, Matheson JM, Kommineri C, Guriel JL, Sugawara T, Luster MI.Impaired cutaneous wound healing in interleukin-6–deficient and immunosuppressed mice.FASEB J2000; 14: 2525–2531.
- 28Duncan MR, Berman B.Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6.J Invest Dermatol1991; 97: 686–692.
- 29Junge K, Binnebösel M, Rosch R, Otto J, Kämmer D, Schumpelick V, Klinge U.Impact of proinflammatory cytokine knockout on mesh integration.J Inves Surg2009; 22: 256–262.
- 30Ornitz DM.FGFs, heparan sulfate and FGFRs: Complex interactions essential for development.Bioessays2000; 22: 108–112.
10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 31Powers CJ, McLeskey SW, Wellstein A.Fibroblast growth factors, their receptors and signaling.Endocr Relat Cancer2000; 7: 165–197.
- 32Sogabe Y, Abe M, Yokoyama Y, Ishikawa O.Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation.Wound Repair Regen2006; 14: 457–462.
- 33Dollenmeier P, Turner CD, Eppenberger HM.Proliferation and differentiation of chick skeletal muscle cells cultured in a chemically defined medium.Exp Cell Res1981; 135: 47–61.
- 34Stratos I, Madry H, Rotter R, Weimer A, Graff J, Cucchiarini M, Mittlmeier T, Vollmar B.Fibroblast growth factor-2-overexpressing myoblasts encapsulated in alginate spheres increase proliferation, reduce apoptosis, induce adipogenesis, and enhance regeneration following skeletal muscle injury in rats.Tissue Eng Part A2011; 17: 2867–2877.
- 35Velleman SG.Extracellular matrix regulation of skeletal muscle formation.J Anim Sci2012; 90: 936–941.
- 36Quirinia A, Viidik A.The effect od recombinat basic fibroblast growth factor (bFGF) in fibrin adhesive on the healing of ischemic and normal incisional skin wounds.Scand J Plast Reconstr Hand Surg1998; 32: 9–18.
- 37Takehara K.Growth regulation of skin fibrosis.J Dermatol Sci2000; 24: S70–S77.
- 38Mani H, Sidhu GS, Kumari R, Gaddipati JP, Seth P, Maheshwari RK.Curcumin differentially regulates TGF-beta 1, its receptors and nitric oxide synthase during impaired wound healing.Biofactors2002; 16: 29–43.
- 39White LA, Mitchell TI, Brinckerhoff CE.Transforming growth factor beta inhibitory element in the rabbit matrix metalloproteinase-1 (collagenase-1) gene functions as a repressor of constitutive transcription.Biochim Biophys Acta2000; 1490: 259–268.
- 40Zeng G, McCue HM, Mastrangelo L, Millis AJ.Endogenous TGF-beta activity is modified during cellular aging: Effects on metalloproteinase and TIMP-1 expression.Exp Cell Res1996; 228: 271–276.
- 41Colwell AS, Phan TT, Kong W, Longaker MT, Lorenz PH.Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.Plast Reconstr Surg2005; 116: 387–390; discussion 1391–1392.
- 42Adzick NS, Lorenz HP.Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair.Ann Surg1994; 220: 10–18.
- 43Junge K, Binnebösel M, von Trotha KT,, Rosch R, Klinge U, Neumann UP, Lynen Jansen P.Mesh biocompatibility: Effects of cellular inflammation and tissue remodeling.Langenbecks Arch Surg2012; 397: 255–270.
- 44Meckmongkol TT, Harmon R, McKeown-Longo P, Van De Water L.The fibronectin synergy site modulates TGFbeta-dependent fibroblast contraction.Biochem Biophys Res Commun2007; 360: 709–714.
- 45Cordeiro MF, Reichel MB, Gay JA, D'Esposita F, Alexander RA, khaw PT.Transforming growth factor-beta1, -beta2, and -beta3 in vivo: Effects on normal and mitomycin C-modulated conjunctival scarring.Invest Ophthalmol Vis Sci1999; 40: 1975–1982.
- 46Tyrone JW, Marcus JR, Bonomo SR, Mogford JE, Xia Y, Mustoe TA.Transforming growth factor beta3 promotes fascial wound healing in a new animal model.Arch Surg2000; 135: 1154–1159.
- 47Shah M, Foreman DM, Ferguson MW.Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.J Cell Sci1995; 108: 985–1002.
- 48Gordon S, Taylor PR.Monocyte and macrophage heterogeneity.Nat Rev Immunol2005; 5: 953–964.
- 49Fairweather D, Cihakova D.Alternatively activated macrophages in infections and autoinmmunity.J Autoinmmun2009; 33: 222–230.
- 50Mantovani A, Sica A, Sozzani S, Alleavena P, Vecchi A, Locati M.The chemokine system in diverse forms of macrophage activation and polarization.Trends Immunol2004; 25: 677–686.
- 51Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Müller W, Roes A, Eming SA.Differential roles of macrophages in diverse phases of skin repair.J Immunol2010; 184: 3964–3977.
- 52Daley JM, Brancato SK, Thomay AA, Reichner JS, Albina JE.The phenotype of murine wound macrophages.J Leukoc Biol2010; 87: 59–67.
- 53Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM.Macrophage phenotype as a determinant of biologic scaffold remodeling.Tissue Eng Part A2008; 14: 1835–1842.
- 54Mirza R, DiPietro LA, Koh TJ.Selective and specific macrophage ablation is detrimental to wound healing in mice.Am J Pathol2009; 175: 2454–2462.
- 55Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Werb Z, Banda MJ.Oxygen tension regulates the expression of angiogenesis factors by macrophages.Science1983; 221: 1283–1285.
- 56Tammela T, Zarkada G, Wallgard E, Murtomäki A, Suchting S, Wirzenius M, Wallgard M, Hellstróm M, Schomber T, Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Ylã-Herttula S, Shibuya M, Pytowski B, Eichmann B, Betsholtz C, Alitalo K.VEGF-3 suppresses angiogenic sprouting and vascular network formation.Nature2008; 454: 656–660.
- 57Hinz B, Gabbiani G.Mechanisms of force generation and transmission by miofibroblast.Curr Opin Biotechnol2003; 14: 538–546.
- 58Valentich JD, Popov V, Saada JI, Powell DW.Phenotypic characterization of an intestinal subepithelial myofibroblast cell line.Cell Physiol1997; 272: C1513–C1524.
- 59Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA.Myofibroblast and mechano-regulation of connective tissue remodeling.Nat Rev Mol Cell Biol2002; 3: 349–363.
- 60Tomasek JJ, Haaksma CJ, Eddy RJ, Vaughan MB.Fibroblast contraction occurs on release of tension in attached collagen lattices: Dependency on an organized actin cytoskeleton and serum.Anat Rec1992; 232: 359–638.
- 61Kelly M, Kolb M, Bonnaiud P, Gauldie J.Re-evaluation of fibrogenetic cytokines in lung fibrosis.Curr Pharm Des2003; 9: 39–49.
- 62Tang L, Eaton JW.Natural responses to unnatural materials: a molecular mechanism for foreign body reactions.Mol Med1999; 5: 351–358.
- 63Arbós MA, Ferrando JM, Vidal J, Quiles MT, Huguet P, Castells J, Segarra A, Armengol M, Schwatz S.Early effects of exogenous arginine after the implantation of prosthetic material into the rat abdominal wall.Life Sci2000; 67: 2493–2512.
- 64Kapischke M, Prinz K, Tepel J, Tensfeldt J, Schulz T.Precoating of alloplastic materials with living human fibroblasts: A feasibility study.Surg Endosc2005; 19: 791–797.
- 65Norton LW, Koschwanez HE, Wisniewski NA, Klitzman B, Reichert WM.Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response.J Biomed Mater Res A2007; 81: 858–869.
- 66Howdieshell TR, Riegner C, Gupta V, Callaway D, Grembowicz K, Sathyanarayana, McNeil PL.Normoxic wound fluid contains high levels of vacular endothelial growth factor.Ann Surg1998; 228: 707–715.
- 67Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L.Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.J Exp Med1992; 176: 1375–1379.
- 68Delavary BM, van der Veer WM, van Egmond M, Niessen FB, Beelen RHJ.Macrophages in skin injury and repair.Immunobiology2011; 216: 753–762.
- 69Simons M.Integrative signaling in angiogenesis.Mol Cell Biochem2004; 264: 99–102.
- 70Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D.Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.J Exp Med1990; 172: 1535–1545.
- 71Broxmeyer HE, Cooper S, Li ZH, Lu l, Song HY, Kwon BS, Warren RE, Donner BD.Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor.Int J Hematol1995; 62: 203–215.
- 72Robson MC, Phillips LG, Lawrence WT, Bishop JB, Youngerman JS, Hayward PG, Broemeling LD, Heggers JP.The safety and effect of topically applied recombinant basic fibroblast growth factor on healing of chronic pressure sores.Ann Surg1992; 216: 401–408.
- 73Steed D. Diabetic Ulcer Study Group.Clinical evaluation of recombinant human platelet derived growth factor (rhPDGF-BB) for the treatment of lower extremity diabetic ulcers.J Vasc Surg1995; 21: 71–81.
- 74Phillips CL, Combs SB, Pinnell SR.Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human dermal fibroblasts.J Invest Dermatol1994; 103: 228–232.
- 75Lateef H, Stevens MJ, Varani J.All-trans-retinoic acid suppresses matrix metalloproteinase activity and increases collagen synthesis in diabetic human skin in organ culture.Am J Pathol2004; 165: 167–174.
- 76Spice PP, Mikos AG.Fibrin glue as a drug delivery system.J Control Release2010; 148: 49–55.
- 77Wong C, Inman E, Spaethe I, Helgerson R.Fibrin-based biomaterials to deliver human growth factors.Thromb Heamost2003; 89: 573–582.
- 78Catelas I, Dwyer JF, Helgerson S.Controlled release of bioactive transforming growth factor beta-1 from fibrin gels in vitro.Tissue Eng2008; 14: 119–128.
- 79Drinnan CT, Zhang G, Alexander MA, Pulido AS, Suggs LJ.Multimodal release of transforming growth factor-beta1 and the BB isoform of platelet derived growth factor from PEGlacted fibrin gels.J Control Release2010; 147: 180–186.
- 80Arkudas A, Tjiawi J, Saumweber A, Beier JP, Polykandriotis E, Bleiziffer O, Horch RE, Kneser U.Evaluation of blood vessel ingrowth in fibrin gel subject to type and concentration of growth factors.J Cell Mol Med2008; 13: 2864–2874.
- 81Arkudas A, Pryymachuk G, Hoereth T, Beier JP, Polykandriotis E, Bleiziffer T, Hoereth T, Hoereth T, Hoereth T, Hoereth T, Hoereth T, Hoereth T.Dose-finding study of fibrin gel-inmobilized vascular endothelial growth factor 165 and basic fibroblast growth factor in the arteriovenous loop rat model.Tissue Eng2009; 15: 2501–2511.
- 82Takaoka R, Hikasa Y, Tabata Y.Vascularization around poly(tetrafluoroethylene) mesh with coating of gelatin hydrogel incorporating basic fobroblast growth factor.J Biomater Sci2009; 20: 1483–1494.
- 83Chen F, Zhang M, Wu Z.Toward delivery of multiple growth factores in tissue engineering.Biomaterials2010; 31: 6279–6308.
- 84Gonzalez R, Ramshaw BJ.Comparison of tissue integration between polyester and polypropylene prostheses in the preperitoneal space.Am Surg2003; 69: 471–476; discussion 476–477.
- 85Jansen PL, Mertens Pr P, Klinge U, Schumpelick V.The biology of hernia formation.Surgery2004; 136: 1–4.
- 86Bellón JM, Buján J, Contreras L, Hernando A.Integration of biomaterials implanted into abdominal wall: Process of scar formation and macrophage response.Biomaterials1995; 16: 381–387.
- 87Marois Y, Cadi R, Gourdon J, Fatouraee N, King MW, Zhang Z, Guidoin R.Biostability, inflammatory response and healing characteristics of a fluoropassivated polyester-knit mesh in the repair of experimental abdominal hernias.Artif Organs2000; 24: 533–543.
- 88Klosterhalfen B, Klinge U, Schumpelick V.Functional and morphological evaluation of different polypropylene-mesh modifications for abdominal wall repair.Biomaterials1998; 19: 2235–2246.
- 89Novitsky YW, Harrell AG, Cristiano JA, Paton BL, Norton HJ, Peindl RD, Kercher KW, Heniford BT.Comparative evaluation of adhesion formation, strength of ingrowth, and textile properties of prosthetic meshes after long-term intra-abdominal implantation in a rabbit.J Surg Res2007; 140: 6–11.
- 90Ferrando JM, Vidal J, Armengol M, Gil J, Manero JM, Huguet P, Segarra A, Quiles MT, Schwartz S, Arbós i Via MA.Experimental evaluation of a new layered prosthesis exhibiting a low tensile modulus of elasticity: Long-term integration response within the rat abdominal wall.World J Surg2002; 26: 409–415.
- 91Gonzalez R, Fugate K, McClusty D 3rd,Ritter EM, Lederman A, Dillehay D, Smith CD, Ramshaw BJ.Relationship between tissue ingrowth and mesh contraction.World J Surg2005; 29: 1038–1043.
- 92Gao Y, Krpata DM, Sadava EE, Rosen MJ, Novitsky YW. Fibroblast coating of synthetic, absorbable, and biologic meshes by human dermal fibroblasts: A comparative analysis.American Hernia Society Annual Meeting,New York, United States;2012.
- 93Orenstein SB, Saberski ER, Klueh U, Kreutzer DL, Novitsky YW.Effects of mast cell modulation on early host response to implanted synthetic meshes.Hernia2010; 14: 511–516.